Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
Medical Oncology
Published in: Medical Oncology 4/2012

01-12-2012 | Review Article

Current principles for radiotherapy in cervical cancer

Authors: Orit Kaidar-Person, Roxolyana Bortnyak-Abdah, Amnon Amit, Alison Berniger, Rahamim Ben-Yosef, Abraham Kuten

Published in: Medical Oncology | Issue 4/2012

Login to get access

Abstract

Cancer of the uterine cervix is most common in countries that do not have access to cervical cancer screening and prevention programs. Treatment of cervical cancer varies significantly between countries (adjusted to stage) and is dependent on medical resources. Radiotherapy for the treatment of gynecological malignancy has been used with different techniques for treating the local tumor and regional lymph nodes. This review discusses recommendations of radiotherapy for cervical cancer according to stage.
Literature
1.
Parkin DM, Bray F, Ferlay J, Pisani P. Global cancer statistics, 2002. CA Cancer J Clin. 2005;55(2):74–108.PubMedCrossRef
2.
3.
Castellsagué X. Natural history and epidemiology of HPV infection and cervical cancer. Gynecol Oncol. 2008;110(3 Suppl 2):S4–7.PubMedCrossRef
4.
Greco A, Mason P, Leung AW, et al. Staging of carcinoma of the uterine cervix: MRI-surgical correlation. Clin Radiol. 1989;40:401–5.PubMedCrossRef
5.
Gaffney DK, Erickson-Wittmann BA, Jhingran A, et al. ACR Appropriateness Criteria® on Advanced Cervical Cancer Expert Panel on Radiation Oncology–Gynecology. Int J Radiat Oncol Biol Phys 2011;81(3):609–14. Epub 2011 Jan 5.
6.
Sironi S, Buda A, Picchio M, et al. Lymph node metastasis in patients with clinical early-stage cervical cancer: detection with integrated FDG PET/CT. Radiology. 2006;238:272–9.PubMedCrossRef
7.
Kizer NT, Thaker PH, Gao F. The effects of body mass index on complications and survival outcomes in patients with cervical carcinoma undergoing curative chemoradiation therapy. Cancer. 2011;117(5):948–56.PubMedCrossRef
8.
Perez CA, Kavanagh BD. Uterine cervix. In: Perez CA, Brady LW, Halperin EC, et al., editors. Principles and practice of radiation oncology. Philadelphia: Lippincott Williams & Wilkins; 2008.
9.
Toita T, Kato S, Niibe Y, et al. Prospective multi-institutional study of definitive radiotherapy with high-dose-rate intracavitary brachytherapy in patients with nonbulky (<4-cm) stage I and II uterine cervical cancer (JAROG0401/JROSG04-2). Int J Radiat Oncol Biol Phys 2011 Apr 4. [Epub ahead of print].
10.
Kinney WK, Alvarez RD, Reid GC, et al. Value of adjuvant whole-pelvis irradiation after Wertheim hysterectomy for early-stage squamous carcinoma of the cervix with pelvic nodal metastasis: a matched-control study. Gynecol Oncol. 1989;34:258–62.PubMedCrossRef
11.
Rose PG, Bundy BN, Watkins EB, et al. Concurrent cisplatin-based radiotherapy and chemotherapy for locally advanced cervical cancer. N Engl J Med. 1999;340:1144–53.PubMedCrossRef
12.
Peters WA 3rd, Liu PY, Barrett RJ 2nd, et al. Concurrent chemotherapy and pelvic radiation therapy compared with pelvic radiation therapy alone as adjuvant therapy after radical surgery in high-risk early-stage cancer of the cervix. J Clin Oncol. 2000;18:1606–13.PubMed
13.
Whitney CW, Sause W, Bundy BN, et al. Randomized comparison of fluorouracil plus cisplatin versus hydroxyurea as an adjunct to radiation therapy in stage IIB-IVA carcinoma of the cervix with negative para-aortic lymph nodes: a Gynecologic Oncology Group and Southwest Oncology Group study. Clin Oncol. 1999;17:1339–48.
14.
Haie-Meder C, Pötter R, Van Limbergen E, et al. Recommendations from Gynaecological (GYN) GEC-ESTRO Working Group (I): concepts and terms in 3D image based 3D treatment planning in cervix cancer brachytherapy with emphasis on MRI assessment of GTV and CTV. Radiother Oncol. 2005;74:235–45.PubMedCrossRef
15.
Pötter R, Haie-Meder C, Van Limbergen E, et al. Recommendations from Gynaecological (GYN) GEC ESTRO Working Group (II): concepts and terms in 3D image-based treatment planning in cervix cancer brachytherapy-3D dose volume parameters and aspects of 3D image-based anatomy, radiation physics, radiobiology. Radiother Oncol. 2006;78:67–77.PubMedCrossRef
16.
Portelance L, Chao KS, Grigsby PW, et al. Intensity-modulated radiation therapy (IMRT) reduces small bowel, rectum, and bladder doses in patients with cervical cancer receiving pelvic and para-aortic irradiation. Int J Radiat Oncol Biol Phys. 2001;51:261–6.PubMedCrossRef
17.
van den Berg HA, Olofsen-van Acht MJ, van Santvoort JP, et al. Definition and validation of a reference target volume in early stage node-positive cervical carcinoma, based on lymphangiograms and CT-scans. Radiother Oncol. 2000;54:163–70.PubMedCrossRef
18.
Taylor A, Rockall AG, Reznek RH, Powell ME. Mapping pelvic lymph nodes: guidelines for delineation in intensity-modulated radiotherapy. Int J Radiat Oncol Biol Phys. 2005;63:1604–12.PubMedCrossRef
19.
Lim K, Small W Jr, Portelance L, et al. Gyn IMRT Consortium. Consensus guidelines for delineation of clinical target volume for intensity-modulated pelvic radiotherapy for the definitive treatment of cervix cancer. Int J Radiat Oncol Biol Phys. 2011;79:348–55.PubMedCrossRef
20.
Jürgenliemk-Schulz IM, Toet-Bosma MZ, de Kort GA, et al. Internal motion of the vagina after hysterectomy for gynaecological cancer. Radiother Oncol. 2011;98:244–8.PubMedCrossRef
21.
Haripotepornkul NH, Nath SK, Scanderbeg D, et al. Evaluation of intra- and inter-fraction movement of the cervix during intensity modulated radiation therapy. Radiother Oncol. 2011;98:347–51.PubMedCrossRef
22.
Nag S, Chao C, Erickson B, et al. American Brachytherapy Society. The American Brachytherapy Society recommendations for low-dose-rate brachytherapy for carcinoma of the cervix. Int J Radiat Oncol Biol Phys. 2002;52:33–48.PubMedCrossRef
23.
Nag S, Erickson B, Thomadsen B, et al. The American Brachytherapy Society recommendations for high-dose-rate brachytherapy for carcinoma of the cervix. Int J Radiat Oncol Biol Phys. 2000;48:201–11.PubMedCrossRef
24.
Wang X, Liu R, Ma B, et al. High dose rate versus low dose rate intracavity brachytherapy for locally advanced uterine cervix cancer. Cochrane Database Syst Rev 2010;(7):CD007563.
25.
Viani GA, Manta GB, Stefano EJ, de Fendi LI. Brachytherapy for cervix cancer: low-dose rate or high-dose rate brachytherapy—a meta-analysis of clinical trials. J Exp Clin Cancer Res. 2009;28:47.PubMedCrossRef
26.
Rath GK, Sharma DN, Julka PK, et al. Pulsed-dose-rate intracavitary brachytherapy for cervical carcinoma: the AIIMS experience. Am J Clin Oncol. 2010;33:238–41.PubMed
27.
Guedea F, Venselaar J, Hoskin P, et al. Patterns of care for brachytherapy in Europe: updated results. Radiother Oncol. 2010;97:514–20.PubMedCrossRef
28.
Hellebust TP, Kirisits C, Berger D, et al. Gynaecological (GYN) GEC-ESTRO Working Group. Recommendations from Gynaecological (GYN) GEC-ESTRO Working Group: considerations and pitfalls in commissioning and applicator reconstruction in 3D image-based treatment planning of cervix cancer brachytherapy. Radiother Oncol. 2010;96:153–60.PubMedCrossRef
29.
Tanderup K, Georg D, Pötter R, et al. Adaptive management of cervical cancer radiotherapy. Semin Radiat Oncol. 2010;20:121–9.PubMedCrossRef
30.
Kerkhof EM, Raaymakers BW, van der Heide UA, et al. Online MRI guidance for healthy tissue sparing in patients with cervical cancer: an IMRT planning study. Radiother Oncol. 2008;88:241–9.PubMedCrossRef
31.
Lin LL, Mutic S, Low DA. Adaptive brachytherapy treatment planning for cervical cancer using FDG-PET. Int J Radiat Oncol Biol Phys. 2007;67(1):91–6.PubMedCrossRef
Metadata
Title
Current principles for radiotherapy in cervical cancer
Authors
Orit Kaidar-Person
Roxolyana Bortnyak-Abdah
Amnon Amit
Alison Berniger
Rahamim Ben-Yosef
Abraham Kuten
Publication date
01-12-2012
Publisher
Springer US
Published in
Medical Oncology / Issue 4/2012
Print ISSN: 1357-0560
Electronic ISSN: 1559-131X
DOI
https://doi.org/10.1007/s12032-012-0170-7

Other articles of this Issue 4/2012

Medical Oncology 4/2012 Go to the issue

Original Paper

Demographic and clinico-pathological characteristics of breast cancer patients with history of oral alendronate use

Original Paper

Upregulation of vasohibin-1 expression with angiogenesis and poor prognosis of hepatocellular carcinoma after curative surgery

Original Paper

PDGFRβ expression in tumor stroma of pancreatic adenocarcinoma as a reliable prognostic marker

Original Paper

Correlation of LAPTM4B polymorphisms with hepatocellular carcinoma in Chinese patients

Short Communication

Severe visual loss in a breast cancer patient on chemotherapy

Original Paper

Comparison of FIGO 1988 and 2009 staging systems for endometrial carcinoma
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Pediatric Cardiology Video

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

Cardiopulmonary Comorbidity Video

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Valvular Heart Disease Video

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.

ACC 2024 Congress Coverage

Heart Failure Video

Year in Review: Heart failure and cardiomyopathies

Watch now

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits